BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhou L, Yu P, Wang T, Du Y, Chen Y, Li Z, He M, Feng L, Li H, Han X, Ma H, Liu H, Zoratti M. Polydatin Attenuates Cisplatin-Induced Acute Kidney Injury by Inhibiting Ferroptosis. Oxidative Medicine and Cellular Longevity 2022;2022:1-14. [DOI: 10.1155/2022/9947191] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Qiao O, Wang X, Wang Y, Li N, Gong Y. Ferroptosis in acute kidney injury following crush syndrome: A novel target for treatment. J Adv Res 2023:S2090-1232(23)00029-2. [PMID: 36702249 DOI: 10.1016/j.jare.2023.01.016] [Reference Citation Analysis]
2 Shi X, Zhuang L, Zhai Z, He Y, Sun E. Polydatin protects against gouty nephropathy by inhibiting renal tubular cell pyroptosis. Int J Rheum Dis 2023;26:116-23. [PMID: 36328529 DOI: 10.1111/1756-185X.14463] [Reference Citation Analysis]
3 Deng L, He S, Guo N, Tian W, Zhang W, Luo L. Molecular mechanisms of ferroptosis and relevance to inflammation. Inflamm Res 2022;:1-19. [PMID: 36536250 DOI: 10.1007/s00011-022-01672-1] [Reference Citation Analysis]
4 Li S, Wang R, Wang Y, Liu Y, Qiao Y, Li P, Chen J, Pan S, Feng Q, Liu Z, Liu D. Ferroptosis: A new insight for treatment of acute kidney injury. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1065867] [Reference Citation Analysis]
5 Jiang Y, Zhao S, Zhou Y, Wei Z. Research progress of traditional Chinese medicine in ferroptosis-related diseases. Medicine in Novel Technology and Devices 2022. [DOI: 10.1016/j.medntd.2022.100193] [Reference Citation Analysis]
6 Tian M, Wang L, Dong Z, Wang X, Qin X, Wang C, Wang J, Huang Q. Preparation, structural characterization, antioxidant activity and protection against cisplatin-induced acute kidney injury by polysaccharides from the lateral root of Aconitum carmichaelii. Front Pharmacol 2022;13:1002774. [DOI: 10.3389/fphar.2022.1002774] [Reference Citation Analysis]
7 Liu Y, Wang J, Badr DA. Ferroptosis, a Rising Force against Renal Fibrosis. Oxidative Medicine and Cellular Longevity 2022;2022:1-12. [DOI: 10.1155/2022/7686956] [Reference Citation Analysis]
8 He M, Feng L, Chen Y, Gao B, Du Y, Zhou L, Li F, Liu H. Polydatin attenuates tubulointerstitial fibrosis in diabetic kidney disease by inhibiting YAP expression and nuclear translocation. Front Physiol 2022;13:927794. [DOI: 10.3389/fphys.2022.927794] [Reference Citation Analysis]
9 Li Z, Zhou L, Du Y, Li H, Feng L, Li X, Han X, Liu H, Badr DA. Polydatin Attenuates Cisplatin-Induced Acute Kidney Injury via SIRT6-Mediated Autophagy Activation. Oxidative Medicine and Cellular Longevity 2022;2022:1-19. [DOI: 10.1155/2022/9035547] [Reference Citation Analysis]
10 Iskander A, Yan LJ. Cisplatin-Induced Kidney Toxicity: Potential Roles of Major NAD+-Dependent Enzymes and Plant-Derived Natural Products. Biomolecules 2022;12:1078. [PMID: 36008971 DOI: 10.3390/biom12081078] [Reference Citation Analysis]
11 Wang T, Du Y, Wang W, Li X, Liu H, Szewczyk-golec K. Inhibition of Xanthine Oxidase Protects against Sepsis-Induced Acute Kidney Injury by Ameliorating Renal Hypoxia. Oxidative Medicine and Cellular Longevity 2022;2022:1-16. [DOI: 10.1155/2022/4326695] [Reference Citation Analysis]
12 Feng Q, Yu X, Qiao Y, Pan S, Wang R, Zheng B, Wang H, Ren KD, Liu H, Yang Y. Ferroptosis and Acute Kidney Injury (AKI): Molecular Mechanisms and Therapeutic Potentials. Front Pharmacol 2022;13:858676. [PMID: 35517803 DOI: 10.3389/fphar.2022.858676] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]